|
Johns Hopkins University School of Medicine
To whom correspondence should be addressed. E-mail : mbae3(at).jhmi.edu
½Å°æ°è(nervous systems)ÀÇ ¹ß´ÞÀº ¸ð¼¼Æ÷(progenitor cells)·Î ºÎÅÍ ¹ß´Þ °ú Á¤À» Á¶ÀýÇÏ´Â ÀÎÀڵ鿡 ÀÇÇØ ÀÌ·ç¾îÁø´Ù. Á¶ÀýÀÎÀÚµéÀº ½Å°æ°è(nervous systems)¸¦ ÀÌ·ç´Â ½Å°æ¼¼ Æ÷(neurons) ¿Í ±× ÁÖº¯ÀÇ ½Å°æÁöÁö¼¼Æ÷(non-neuronal cells)¿¡ ¿µÇâÀ» ÁÖ¾î Á¶ÀýÀÎÀڷμÀÇ ¿ªÇÒ À» ÇÏ°Ô µÈ´Ù. Hepatocyte growth factor/scatter factor´Â pleiotropic factor·Î½á ¹ß»ý °úÁ¤¿¡¼ ´Ù¾çÇÑ ¿ªÇÒÀ» ÇÑ´Ù. HGF/SF´Â ¼ö¿ëüÀÎ Met, tyrosine kinase receptor¿¡ ºÙ¾î ¼¼Æ÷ÀÇ Áõ½Ä (proliferation), À̵¿(motility), ¼º¼÷(morphogenesis), °¡ÁöÀÇ ¼ºÀå(neurite extension), ¼¼Æ÷ »ýÁ¸(anti-apoptotic activities)À» À¯µµÇÑ´Ù (Maina and Klein, 1999; Stella and Comoglio, 1999; Birchmeier et al., 2003). ƯÈ÷ in vitro ¿Í in vivoÀÇ ½ÇÇèÀ» ÅëÇØ¼ HGF/SFÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ º¸È£ ±â´É¿¡ ´ëÇÑ ¸¹Àº ¿¬±¸µéÀÌ º¸°íµÇ°í ÀÖ´Ù (Wong et al., 1997; Yamamoto et al., 1997; Novak et al., 2000). ÀÌ·± ¸¹Àº ¿¬±¸µéÀº HGF/SF°¡ ÁßÃ߽Űæ°è ½Å°æ¼¼Æ÷ÀÇ »ç¸êÀ» ¸·°í ´õ ³ª¾Æ °¡ ½Å°æ°èÀÇ ºñÁ¤»óÀû ±â´ÉÀ» ¸·´Â Ä¡·áÁ¦ °³¹ßÀÇ °¡´É¼ºÀ» Á¦½ÃÇϰí ÀÖ´Ù.
JHIBRG Home Page |